SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is trending downwards as the community discusses disappointing guidance and the impact of tariffs after earnings. Discussions include concerns about management, product strategy, and competition, with some suggesting the brand's premium pricing is becoming a barrier. Despite this, some bulls remain optimistic about the long-term potential, citing international growth and a strong balance sheet.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor ($OPEN) is trending as community members discuss its potential for a significant upward move, drawing comparisons to meme stocks like $GME and $AMC, while emphasizing the company's fundamentals and potential for profit. Some traders are pointing to a possible short squeeze and gamma squeeze, as well as positive catalysts such as potential rate cuts and a new CEO announcement. The community also mentions a possible influence of activist investors on the stock.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending as community members discuss potential price movements and the recent Alpenglow upgrade, which aims to significantly boost transaction speeds.  Discussion is centered around meme coins on the Solana network, with some users highlighting projects, while others are focused on staking $SOL.X for rewards.

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Rigel Pharmaceuticals

RIGL is trending amid analyst optimism fueled by strong underlying business momentum and reiterated buy ratings, with some analysts suggesting significant upside. Investors are focused on the company's potential for 50% growth in 2025, pipeline expansion, and financial discipline, as highlighted in a recent Cantor conference. Community members are closely watching investor meetings and speculating about potential acquisitions, particularly after positive presentations by Rigel's CEO.

Brandy was a curious blend of two well-loved icons from the Boy’s Club comics. When their digital essences combined, the result was Brandy—a creature who embodied the best of both worlds and became an inspiration for everyone. As Brandy engaged with fans, it naturally sparked discussions about everything from the latest trends to the best crypto in the market. BRANDY token launched at 20th of May 2025 is a meme token on the Solana blockchain.

BRANDY

$BRANDY.X is trending as community members discuss its potential as a 'sleeper gem' with 'rocket vibes'. The conversation is centered around its potential for significant gains, with many mentioning 'moon' targets. However, some users are also warning of potential scam activity, advising caution due to concerns about top holders.

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives, Antibody Therapeutics, Devices, and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Emergent Biosolutions Inc

EBS is trending as investors discuss management's confident outlook and potential buyout scenarios, particularly following recent commentary from the CEO. The community is also reacting to news of an Ebola outbreak and the potential for increased orders for EBS's FDA-approved treatment. Bullish sentiment is further fueled by technical indicators and strong buy ratings, with some anticipating a significant reversal and short squeeze.

Asset Entities, Inc. engages in providing social media marketing and content delivery services. It offers its services to Discord, TikTok, and other social media platforms. It also designs, develops and manages servers for communities on Discord. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani and Kyle Fairbanks on August 1, 2020 and is headquartered in Dallas, TX.

Asset Entities Inc - Ordinary Shares - Class B

Asset Entities Inc.

ASST is trending due to anticipation surrounding its upcoming merger vote with Strive Enterprises, fueling speculation of a potential short squeeze. The community is focused on the high short interest and cost to borrow, with many expressing conviction that shorts will be forced to cover. Some traders are closely watching technical indicators and dark pool activity, while others remain cautious about potential dilution post-merger.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath ($PATH) is trending as investors discuss its potential for a short squeeze, citing a high short float and above-average volume, while some caution about possible CEO share sales.  The community is analyzing recent earnings, revenue growth, and partnerships, debating whether the stock is undervalued and poised for a significant reprice amid the broader AI and automation sector. Despite some analyst downgrades, there's optimism surrounding UiPath's long-term potential in the robotic AI space.

Solana Street Bets is not just a memecoin; it's a symbol of creativity, humor, and the power of a united community. Inspired by the infamous /wallstreetbets subreddit. Solana Street Bets is here to put respect on the Wall St originated memes in the industry. Solana Street Bets is a decentralized Solana meme coin inspired by the infamous /wallstreetbets subreddit.

SatoshiStreetBets

SatoshiStreetBets (SSB.X) is gaining traction as community members discuss potential rocket launches, focusing on new projects like $BRANDY.X, $RONNIE.X, $TRDX.X, $NEXEA.X, $AILESS.X, $MIYO.X, $FAIRLY.X, $QRINGE.X, $APET.X, $WOMEN.X, $STYLEX.X and $SNFL.X; while some users express concerns about scams and project legitimacy, others highlight the upcoming migration to Litecoin and staking opportunities.

American Eagle Outfitters, Inc. is a multi-brand specialty retailer, which offers an assortment of apparel and accessories for men and women under the American Eagle Outfitters brand, and intimates, apparel and personal care products for women under the Aerie brand. The firm operates stores in the United States, Canada, Mexico, Hong Kong, China and the United Kingdom. It also acquired two emerging brands to complement its existing brands, Tailgate, a vintage sports-inspired apparel brand, and Todd Snyder New York, a premium menswear brand. The company was founded in 1977 and is headquartered in Pittsburgh, PA.

American Eagle Outfitters Inc.

American Eagle Outfitters, Inc.

American Eagle Outfitters is trending due to a strong earnings report and positive reception to marketing campaigns, particularly the "Great Jeans" campaign featuring Sydney Sweeney. The community is discussing the potential for a short squeeze, fueled by high short interest and the expectation that the stock will continue to rise based on the brand's appeal and successful marketing strategies. Broader context includes renewed investor enthusiasm around the retail sector.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Short Interest in Avenue Therapeutics, Inc. (NASDAQ:ATXI) Expands By 91.7%

Avenue Therapeutics, Inc. (NASDAQ:ATXI - Get Free Report) was the target of a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 313,400...

Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024

MIAMI, March 25, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) ( Avenue or the Company ), a specialty pharmaceutical company focused on the development and commercialization...

Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights

- Enrollment completed in Phase 1b/2a clinical trial of AJ201 for spinal and bulbar muscular atrophy; topline data expected in second quarter of 2024 - - Presented positive BAER-101 preclinical...

Avenue Therapeutics granted extension for Nasdaq compliance

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Avenue Therapeutics Receives Positive Listing Determination from Nasdaq

MIAMI, March 15, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) ( Avenue or the Company ), a specialty pharmaceutical company focused on the development and commercialization...

Avenue Therapeutics to Present BAER-101 Preclinical Data at American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual Meeting

BAER-101 demonstrated full suppression of seizure activity in SynapCell's GAERS model of absence epilepsy, a proven indicator of efficacy in anti-seizure drug development with high predictability of...

Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy

-In vivo data supports BAER-101's unique ability to significantly suppress seizures using the SynapCell's Genetic Absence Epilepsy Rat from Strasbourg ( GAERS ) model of absence epilepsy-MIAMI, Feb...

Avenue Therapeutics, Inc. (NASDAQ:ATXI) Sees Large Growth in Short Interest

Avenue Therapeutics, Inc. (NASDAQ:ATXI  Get Free Report) was the recipient of a significant increase in short interest during the month of January. As of January 15th, there was short interest...

Avenue Therapeutics to Present at Sidoti January Micro-Cap Investor Conference

MIAMI, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) ( Avenue or the Company ), a specialty pharmaceutical company focused on the development and commercialization of...

Why Avenue Therapeutics Shares Are Getting Hammered

Avenue Therapeutics Inc (NASDAQ: ATXI) shares are trading lower by 31% to $0.24 Friday morning after the company announced it has entered into warrant exercise agreements with existing read more...

Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, a potential alternative that could reduce the use of conventional opioids for patients suffering from acute pain. The company was founded on February 9, 2015 and is headquartered in Bay Harbor Islands, FL.

ATXI
Avenue Therapeutics Inc

Feed

News

Sentiment

Fundamentals

Info

Latest ATXI News

ATXI Avenue Therapeutics Inc